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EchocardiographyAbstract Objective: To differentiate cystic and cylindrical bronchiectasis utilizing a diagnostic
triad of HRCT score, PFTs, and echocardiography.
Design: A prospective observational cross sectional study.
Setting: All bronchiectasis patients admitted to the chest department of Assiut and Al-Azhar
Universities from May 2012 to June 2014 were enrolled in this study.
Main outcome measures: HRCT score, pulmonary function tests parameters (FEV1, FEV1/
FVC, FVC, PaO2, PaCO2 and DLCO) and complete echocardiographic assessment were done
for all patients.
Results: Obstructive pulmonary defect was observed in a majority of patients (56%). FVC%,
FEV1 and FEV1/FVC were lower in patients with cylindrical as compared to cystic bronchiectasis.
RV diameter was signiﬁcantly greater in cystic bronchiectasis, and was positively correlated with
pulmonary hypertension and negatively correlated with PaO2. PH was signiﬁcantly greater in
patients with cystic bronchiectasis and was positively correlated with PaCO2, and inversely
correlated with PaO2, and FEV1. Global HRCT scores for cystic bronchiectasis were signiﬁcantly
correlated with the values of FEV1% and with SPAP.
Conclusions: Cystic bronchiectasis is associated with more severe lung function impairment and
worse HRCT scores as compared with cylindrical bronchiectasis. In cystic bronchiectasis, HRCT
scores correlated with FEV1% and SPAP and could be a predictor of future PH. HRCT depicts
these pathological changes, moreover, high HRCT score not only reﬂects lung damage in those
patients, but it can also be correlated with PH. PH; therefore can be a marker of lung damage in
bronchiectatic patients.
ª 2015 Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest Diseases and
Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Introduction
High-resolution CT (HRCT) of the chest has become the
imaging technique of choice, in the diagnosis of bronchiectasis.
It helps to detect ﬁndings that are not seen on plain chest
radiographs, as well as classify different pathological
types and determine the extent of bronchiectasis [1,2]. The
478 W.A. Hassan et al.combination of the clinical features of severe lung disease and
echocardiographic evidence of pulmonary hypertension or
right ventricular dysfunction is associated with a poor
prognosis. Several different echocardiographic techniques have
been used to assess right ventricular function and pulmonary
artery pressure in bronchiectasis. Doppler echocardiography
estimates of pulmonary artery pressure using the peak velocity
of tricuspid regurgitant jet are a reliable non-invasive way of
measuring pulmonary artery pressure [3]. Pulmonary function
studies may be normal in localized and mild bronchiectasis.
With more severe and diffuse disease, pulmonary function tests
may show obstructive or combined obstructive and restrictive
abnormalities. Evidence of hyperinﬂation and reduced carbon
monoxide diffusing capacity, may also be seen. In addition,
between 30% and 69% of patients with bronchiectasis, have
evidence of airway hyper responsiveness, as evident by
histamine or methacholine challenge test [4].
Aim of the work
This study aims to differentiate cystic from cylindrical bronch-
iectasis utilizing a diagnostic triad of HRCT score, PFTs, and
echocardiography.
Patients and methods
We included 100 patients who had been admitted for cough,
chronic sputum production and radiological changes consis-
tent with bronchiectasis including HRCT.
HRCT interpretation
HRCT scans were obtained on 16 rows HRCT (GE medical
systems) scanner. Images were obtained at 1 mm collimation
at 1-mm intervals from the apices to the lung bases, 0.5-s gan-
try rotation time, 120 kVp, and 130 mAs during maximum
inspiration with the patient supine and extending from lung
apex to diaphragm. All images were displayed at a window
level of 700 Hounsﬁeld units (HU) and at window width of
1500 HU, as appropriate for lung parenchyma. Two radiolo-
gists who were blinded to the clinical and laboratory data, used
according to recommendations of the Nomenclature
Committee of the Fleischner Society [5]. The CT scan was
interpreted for the presence of bronchiectasis severity, pattern,
distribution, and associated disease processes such as
emphysema and small airway disease. Bronchiectasis was
deﬁned as a bronchus with an internal diameter larger than
its accompanying pulmonary artery, lack of tapering of the
bronchial lumen for longer than 2 cm, and visualization of a
bronchus within 1 cm of the costal pleura. Peribronchial
thickening was characterized by a bronchial wall thicker than
1 mm. Cylindrical bronchiectasis was diagnosed based on
dilatation and thickening of the bronchial wall arterial wall
ratio >1 [5] and cystic bronchiectasis was diagnosed by
noticing thin-walled cystic spaces that may contain ﬂuid and
these were seen in subsequent axial cuts either in a
conglomerate fashion or in branching order [6]. The HRCT
scoring system used in the present study was a modiﬁed
Bhalla CT scoring system. Six CT scan criteria were assessed:
(1) bronchial dilatation, (2) peribronchial wall thickening, (3)
number of bronchiectasis segments, (4) number of bullae, (5)number of emphysema segments, and (6) criteria of associated
small airway disease. Each of the above parameters were
scored from 0 in absence of a lesion through 3 according to
severity of disease, with the small airway disease scored as 0
if it was absent or 1 if it was present. A global score for each
patient was calculated from these measures that reﬂected the
radiological overall severity of the disease process and its
associations, with a maximum possible score of 16 [7].
Pulmonary function tests
Forced spirometry and the single-breath Carbon monoxide
diffusing capacity of the lung (DLco) were obtained with pul-
monary function units (Spirolab MIR, Italy). The Forced vital
capacity (FVC) and DLCO were expressed as a percentage of
predicted value based on height, age, gender and ethnic origin.
Measurement of forced vital capacity (FVC) and forced
expiratory volume in the ﬁrst second (FEV1; best results of 3
successful attempts) was done in all patients. Total lung capac-
ity (TLC) and residual volume were measured by plethys-
mography to diagnose cases with mixed obstructive and
restrictive defects. Data were expressed as percentage of pre-
dicted value using the standard protocol of the American
Thoracic Society [8]. Arterial blood gases were measured while
patients were breathing room air. Hypoxemia and hypercarbia
were deﬁned as PaO2 <60 mmHg and PaCO2 >45 mmHg
respectively.
Echocardiography
Two-dimensional transthoracic cardiographs with color ﬂow
imaging were performed in all patients (Philips model 5500).
The ECHO study was read by a cardiologist without informa-
tion about patient status. Pulmonary hypertension (PH) was
deﬁned in this study as SPAP P40 mmHg based on criteria
established by the World Health Organization Symposium
on Primary Pulmonary Hypertension [9]. SPAP was calculated
based on the modiﬁed Bernoulli equation, and right atrial
pressure was estimated as 5, 10, 15, or 20 mmHg on the basis
of size and respiratory changes of the inferior vena cava using
previously described techniques [10]. Assessment of LV
systolic function by calculating ejection fraction (EF) using
M-mode method: normally >55%. Assessment of LV diasto-
lic function by detecting transmitral early velocity wave (E
wave) and transmitral late velocity wave (A wave).
(Normally E/A ratio >0.8). Assessment of RV systolic
function by calculating fractional area Change (FAC)
(Normally; 35–60%) and tricuspid annular peak systolic
excursion (TAPSE) (Normal value >16 cm). Assessment of
RV diastolic function by detecting tricuspid early velocity
wave (E wave) and tricuspid late velocity wave (A wave).
(Normally E/A ratio >0.8), and by measuring deceleration
time (DT). (Normally <220 ms) [11,12].
Statistical analysis
SPSS (SPSS for Windows, SPSS Inc., Chicago, IL, USA) sta-
tistical package were used for statistical analyses. Descriptive
statistics were shown as mean ± S.D. Univariate analysis
was performed using chi-square test for proportion of sex
differences in the study and variable groups. To compare
Table 2 Echogardiographic data in cystic and cylindrical
bronchiectasis.
Variables Cystic
(n= 65)
Cylindrical
(n= 35)
P value
Mean ± SD Mean ± SD
mPAP 48.7 ± 8.7 33.3 ± 6.1 <0.001
SPAP 76.2 ± 14.2 50.8 ± 10 <0.001
RVD 3.5 ± 0.6 2.6 ± 0.3 <0.001
LVSF assessed by EF 63.3 ± 3.6 64.9 ± 4.6 0.061
LVDF assessed by
MV E/A ratio
1.11 ± 1.7 1.23 ± 0.28 0.756
RVSF assessed by
FAC
33.43 ± 10.76 50.85 ± 10.33 0.001
RVSF assessed by
TAPSE
14.33 ± 4.25 19.55 ± 2.95 0.001
Assessed by DT 282.6 ± 9.37 249.95 ± 16.09 0.001
RVDF assessed by TV
E/A ratio
0.65 ± 0.1 0.6 ± 0.13 0.123
mPAP, mean pulmonary artery pressure; SPAP, systolic pul-
monary artery pressure; RVD, right ventricle diameter; LVSF, left
ventricle systolic function; EF, ejection fraction; LVDF, left ven-
tricle diastolic function; MV E/A, Transmitral early velocity wave
(E wave)/Transmitral late velocity wave (A wave); RVSF, right
ventricle systolic function; FAC, fractional area change; TAPSE,
tricuspid annular peak systolic excursion; RVDF, right ventricle
diastolic function; DT, deceleration time; TV E/A, tricuspid early
velocity wave (E wave)/tricuspid late velocity wave (A wave).
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tion, mean HRCT and lung function parameters, Student’s t-
test was used. Correlation of the right ventricle diameter with
lung function parameters and HRCT score was investigated by
Pearson correlation test. A p value less than 0.05 was consid-
ered statistically signiﬁcant.
Results
Demographic data
This study was conducted at department of Chest Diseases of
Assiut and Al-Azhar universities, Assiut, Egypt from
September 2012 to May 2014, all consecutive patients with
bronchiectasis admitted to the department were enrolled to the
study.All patientswere subjected to history taking, clinical exam-
ination and routine investigations. Pulmonary function tests
(PFT), high resolution computerized tomography (HRCT) and
echocardiography, were done to all cases. This study included
100 patients, of whom 47 were men and 53 were women. The
mean (SD) age was (53 ± 13) years. Cystic bronchiectasis was
diagnosed in 65 patients (65%) and cylindrical in 35 patients
(35%). Productive cough was the most common symptom,
whereas clubbing of ﬁngers was found in only 14%of all patients.
Pulmonary function tests data
Obstructive pulmonary defect was observed in a majority of
patients (56%), restrictive dysfunction in 17% and mixed
defect in 13% whereas normal function was in 14%. There
was a statistically signiﬁcant difference between cystic and
cylindrical groups in relation to the mean values of FVC%,
FEV1%, FEV1/FVC, PCO2 and PO2. FVC%, FEV1 and
FEV1/FVC were lower in patients with cylindrical bronchiec-
tasis as compared to the cystic group (Table 1).
Echocardiographic data
RV diameter was signiﬁcantly greater in the cystic than
cylindrical bronchiectasis group (Table 2), and was positively
correlated with SPAP (r= 0.53, p= 0.000) and negativelyTable 1 Pulmonary function test data in cystic and cylindrical
bronchiectasis.
Variables Cystic
(n = 65)
Cylindrical
(n= 35)
P-value
FEVI/FVC 69.1 ± 4.3 61.5 ± 6.8 0.016
FEVI (%
predicted)
65.8 ± 19.3 49.2 ± 18.6 <0.0001
FVC (%
predicted)
56.8 ± 14.7 77.0 ± 17.1 <0.0001
DLCO (%
Predicted)
58.3 ± 18.7 70.9 ± 17.4 0.001
PaO2 (mmHg) 59.9 ± 12.7 70.8 ± 9.8 <0.0001
PaCO2 (mmHg) 44.1 ± 11.7 37.2 ± 4.5 0.001
DLCO, diffusion of the lung for carbon monoxide; PaCO2, partial
arterial CO2 pressure; FVC, forced vital capacity; FEV1, forced
expiratory volume in 1st second; PaO2, partial arterial oxygen
pressure.correlated with PaO2 (p= 0.005). PH was signiﬁcantly greater
in patients with cystic bronchiectasis as compared with cylin-
drical bronchiectasis (p< 0.001). In cystic bronchiectasis,
SPAP was positively correlated with PaCO2 (p= 0.001), and
inversely correlated with PaO2 (p= 0.001), and FEV1
(p= 0.000) (Fig. 1). Right ventricular (RV) systolic
dysfunction was signiﬁcantly found in patients who had cystic
bronchiectasis than patients with cylindrical bronchiectasis
whereas left ventricular (LV) systolic dysfunction and LV dia-
stolic dysfunction were insigniﬁcantly observed in both types
of bronchiectasis.Figure 1 Correlations between SPAP and FEV1 in cystic
bronchiectasis.
Figure 3 Correlation between SPAP and global HRCT score in
cystic bronchiectasis.
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In cystic group, there was also a statistically signiﬁcant
increase in global HRCT score, extent and degree than cylin-
drical group (Table 3). Global HRCT scores for all types of
bronchiectasis patients were statistically signiﬁcantly nega-
tively correlated with the values of FEV1% (r= 0.52,
p= 0.003). (Fig. 2) and signiﬁcantly positively correlated with
SPAP (r= 0.17, p = 0.004) (Fig. 3).
Discussion
Obstructive pulmonary defect was reported in a majority of
our patients with bronchiectasis (56%), and FVC% and
FEV1%, FVC/FEV1 were lower in patients with cylindrical
bronchiectasis as compared with the cystic group. The cystic
group had signiﬁcantly lower DLCO% and FVC% than the
cylindrical group. Lynch et al. showed that airﬂow obstruction
was common in 33 patients in a study done on 261 patients
[13]. Our study is in agreement with their report; the cause
of airﬂow obstruction, most likely bronchiolitis, secretion,
and bronchial hyper-responsiveness. Hansel et al. studied areas
of decreased attenuation using HRCT and concluded that
small airway disease and inﬂammatory bronchiolitis are inte-
gral part of bronchiectasis [14]. In their study, bronchiolitis
was also found in lobes that were free of bronchiectasis,
suggesting that bronchiolitis may precede the development of
bronchiectasis and that small airways are affected before large
airways [15].The cystic group had signiﬁcantly lower DLCO%
and FVC% than the cylindrical group. These further supportTable 3 HRCT score, degree and extent in both types of
bronchiectasis.
Variables Cystic (n= 65) Cylindrical (n= 35) P value
HRCT score 8.7 ± 1.8 7.2 ± 2.8 0.002
Degree 2.64 ± 0.5 1.9 ± 0.7 <0.0001
Extent 2.42 ± 0.5 2.01 ± 0.78 0.002
Figure 2 Correlations between global HRCT score and FEV1 in
cystic bronchiectasis.the restrictive component of their disease, which is presumably
related to atelectasis, bullae, emphysema, and ﬁbrosis,
representing a late irreversible disease commonly seen in these
patients [16].
Hypoxemia and hypercapnia were seen more in cystic
group. A previous study of regional ventilation in bronchiecta-
tic patients using Xenon-133 scintigraphy demonstrated
reduced ventilation that was widespread even in non bronch-
iectatic areas [17]. Ashore studied hemodynamics in bronchiec-
tasis using V/Q scan and pulmonary angiography [18]. Ashore
found that the cystic group had more capillary bed destruction
and extensive anastomosis between pulmonary and bronchial
arteries, with greater likelihood of compromised gas exchange
[18]. Furthermore, in advanced bronchiectasis the respiratory
muscles are exposed repetitively to increased work because of
hyperinﬂation and alteration of the length-tension relationship
[19]. Previous study demonstrated an expiratory ﬂow
limitation in patients with bronchiectasis, which further
contributes to ventilatory defect in these patients [20].
Spirometry results were normal in 14% of patients while
HRCT scans depicted structural abnormalities this observa-
tion was reported before since CT scans directly quantify
lung structural abnormalities associated with bronchiectasis
and PFTs indirectly measure pulmonary function to give a
global assessment and can be even normal in milder disease
[21].
In this study, patients with cystic disease were found to
have signiﬁcantly higher HRCT scores, with more extensive
disease and more bronchiectatic lobe involvement. We also
found a negative correlation between HRCT score and
FEV1%. This is in agreement with previous reports; as the
HRCT score reﬂects bronchiolitis, areas of emphysema, bullae,
and bronchiectatic segments all can affect FEV1% measure-
ments [22,23].
In this study, SPAP was positively correlated with HRCT
score. PH is commonly seen in advanced bronchiectasis, par-
ticularly with cystic disease [9]. It was reported that 32.9%
of stable patients with bronchiectasis had PH and SPAP was
higher in cystic bronchiectasis with concomitant right and left
ventricular dysfunction [9]. The pathogenesis of PH in these
patients is related to impairment of pulmonary physiology
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resistance. This is presumably due to extensive anastomosis
between pulmonary and bronchial arteries and the presence
of hypoxemia, which further contribute to higher SPAP [24].
In our patients, cystic bronchiectasis had more RV systolic
dysfunction and PH than cylindrical bronchiectasis. LV
diastolic dysfunction was seen mainly in severe disease with
no signiﬁcant difference between both types of bronchiectasis.
Moreover, SPAP was higher in cystic bronchiectasis than
cylindrical bronchiectasis and may indicate deteriorating pul-
monary function. RV systolic dysfunction was observed in
patients with cystic bronchiectasis.
Tomlin et al. described chronic corpulmonale as a
complication of ﬁbrocystic disease of the pancreas in 1952
[25]. Vizza et al. examined RV and LV function in patients
with severe airway, parenchymal, and pulmonary vessel dis-
ease; the presence of RV dysfunction varied between 59%
and 94% [26]. Two other studies of patients with cystic ﬁbrosis
showed disparate RV dysfunction rates of 0% and 72%,
Koelling et al. observed that RV systolic function at rest and
after peak exercise was similarly compromised in 40 patients
with advanced cystic ﬁbrosis, as well as in 9 patients with mod-
erately severe bronchiectasis [27]. They also noticed abnormal
diastolic function in patients with cystic ﬁbrosis compared with
control subjects or patients with bronchiectasis. In their study,
however, patients with cystic ﬁbrosis had greater impairment
of pulmonary function than those with bronchiectasis.
Although none of our patients was subjected to exercise, we
expect more patients in our cohort would exhibit impairment
of RV function if they were stressed by exercise.
We also found that RV dimensions were signiﬁcantly
greater in patients with cystic bronchiectasis compared with
cylindrical disease (p< 0.001). Moreover, hypoxemia and
hypercapnia were seen more frequently in this group of
patients. In cystic group, a close correlation between RV
dimensions and both PaO2, and pulmonary artery pressure.
These ﬁndings conﬁrm the important role of hypoxemia and
PH in the pathophysiology of RV dysfunction, which has been
described before in other pulmonary diseases [11,28].
Previous studies in patients with other chronic lung diseases
regarding LV dysfunction are rare. Vizza et al. reported that
LV dysfunction was present in 6% of patients with advanced
stage of different pulmonary diseases, with a higher prevalence
in patients with PH [26]. In this study, LV systolic dysfunction
was observed in both types of bronchiectasis without
signiﬁcant difference. Nevertheless, these ﬁndings suggest that
abnormal LV performance may be due to ventricular
interdependence, in which RV dilatation leads to bulging of
the septum into the LV, which in turn increases LVEDD,
decreases LV performance, and alters left atrium mechanics.
This is in agreement with previous reports on the cause of
LV diastolic dysfunction in patients with PH [27]. The etiology
of the observed PH in our patients is potentially multifactorial.
Liebow and others described several pathologic changes in
bronchiectasis, including dilatation and hypertrophy of
bronchial circulation with extensive bronchopulmonary
anastomosis, which can lead to left-to-right shunt [29].
Ashour demonstrated, using right sided pulmonary angiogra-
phy, that pulmonary artery ﬂow was absent in the destroyed
segment, while there was a retrograde ﬁlling of the pulmonary
artery through bronchial circulation demonstrated by
thoracic aortography [18]. Darke and Lewtas, described thisphenomenon as reversal of pulmonary artery ﬂow [30]. These
changes were mainly seen in cystic bronchiectasis and were
described as non perfused segments. These hemodynamic alter-
ations increase right-sided afterload due to the contribution of
systemic pressure on pulmonary vascular resistance, which fur-
ther increases the pulmonary artery pressure. There was nega-
tive correlation of SPAP with FEV1 in this study. This
negative correlation was seen in cystic disease, whereas no
correlation was found in cylindrical bronchiectasis, suggesting
that the latter disease has a more favorable course [31].
SPAP correlated negatively with FEV1 in our patients with
cystic bronchiectasis. A previous study on bronchiectasis
emphasized that obstructive pulmonary insufﬁciency was
related to morphologic changes and bronchial responsiveness
[28]. Obliterative bronchiolitis of small and medium airways
together with secretions and associated emphysematous
changes all contribute to pulmonary function deterioration
associated with obstructive disease [32]. Sustained hypoxia
has been implicated in the pathogenesis of PH in animals
and humans and was found to be an important stimulus for
vascular remodeling resulting in vasoconstriction, which in
turn leads to an increase in pressure and wall stress [33]. We
found a correlation between high SPAP and low PaO2 and
high PaCO2, suggesting a consequence of poor gas exchange
on SPAP. The above ﬁndings of deteriorating pulmonary
physiology, particularly in patients with cystic bronchiectasis,
have an important role in the pathogenesis of PH and suggest
that PH is a marker of lung damage in these patients.
In conclusion, cystic bronchiectasis is associated with more
severe lung function impairment and worse HRCT scores as
compared with cylindrical bronchiectasis. In cystic bronchiec-
tasis, HRCT scores correlate with FEV1% and SPAP and
could be a predictor of future PH. HRCT depicts these patho-
logical changes, moreover, high HRCT score not only reﬂects
lung damage in these patients, but it can also be correlated
with PH. PH; therefore can be a marker of lung damage in
bronchiectatic patients.Conﬂict of interest
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